MC2150A1 - USE OF ALKYLPHOPHORIC ACID DERIVATIVES FOR THE CONTROL OF PSORIASIS DISEASES - Google Patents

USE OF ALKYLPHOPHORIC ACID DERIVATIVES FOR THE CONTROL OF PSORIASIS DISEASES

Info

Publication number
MC2150A1
MC2150A1 MC902151A MC2151A MC2150A1 MC 2150 A1 MC2150 A1 MC 2150A1 MC 902151 A MC902151 A MC 902151A MC 2151 A MC2151 A MC 2151A MC 2150 A1 MC2150 A1 MC 2150A1
Authority
MC
Monaco
Prior art keywords
alkylphophoric
control
acid derivatives
psoriasis diseases
psoriasis
Prior art date
Application number
MC902151A
Other languages
French (fr)
Inventor
Hansjoerg Eibl Prof
Clemens Unger Dr
Dr Juergen Engel Prof
Original Assignee
Asta Pharma
Max Planck Gesellschaft
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=6390272&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=MC2150(A1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Asta Pharma, Max Planck Gesellschaft filed Critical Asta Pharma
Publication of MC2150A1 publication Critical patent/MC2150A1/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A61K31/685—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols one of the hydroxy compounds having nitrogen atoms, e.g. phosphatidylserine, lecithin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/664—Amides of phosphorus acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/66—Phosphorus compounds
    • A61K31/683—Diesters of a phosphorus acid with two hydroxy compounds, e.g. phosphatidylinositols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/10—Antimycotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Immunology (AREA)
  • Oncology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
MC902151A 1989-09-27 1990-09-25 USE OF ALKYLPHOPHORIC ACID DERIVATIVES FOR THE CONTROL OF PSORIASIS DISEASES MC2150A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3932183 1989-09-27

Publications (1)

Publication Number Publication Date
MC2150A1 true MC2150A1 (en) 1992-03-10

Family

ID=6390272

Family Applications (1)

Application Number Title Priority Date Filing Date
MC902151A MC2150A1 (en) 1989-09-27 1990-09-25 USE OF ALKYLPHOPHORIC ACID DERIVATIVES FOR THE CONTROL OF PSORIASIS DISEASES

Country Status (17)

Country Link
EP (2) EP0916343A1 (en)
JP (1) JP3176615B2 (en)
CA (1) CA2026278C (en)
DD (1) DD298052A5 (en)
DE (1) DE4029747C2 (en)
EG (1) EG19338A (en)
FI (1) FI904726A0 (en)
HU (1) HU209589B (en)
IE (1) IE903464A1 (en)
LT (1) LT3804B (en)
LV (1) LV10391B (en)
MC (1) MC2150A1 (en)
NO (1) NO904184L (en)
PT (1) PT95422B (en)
RU (1) RU1837877C (en)
UA (1) UA19335A (en)
ZA (1) ZA907702B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5958906A (en) * 1992-10-01 1999-09-28 Asta-Medica Aktiengesellschaft Phospholipid derivatives containing higher elements of the fifth main group
DE4233044A1 (en) * 1992-10-01 1994-04-07 Asta Medica Ag Phospholipid derivatives that contain higher elements of the 5th main group
DE4235911A1 (en) * 1992-10-23 1994-04-28 Asta Medica Ag Stabilized hexadecylphosphocholine solutions in glycerol alkyl ethers
NZ505648A (en) 1998-01-22 2002-10-25 Zentaris Ag Hexadecylphosphocholine (HPC) and a flow controlling agent and/or a lubricant and a filler in a daily dosage of 10-250 mg
DE102006004821B4 (en) * 2006-01-30 2020-12-10 Cuma Kilic Collection container for waste and building rubble
BR112012000476A2 (en) 2009-07-09 2016-11-22 Expergen Drug Dev Gmbh liquid pharmaceutical form of alkylphosphocholine and method of preparation thereof.

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4761404A (en) * 1985-07-01 1988-08-02 Merck & Co., Inc. Phospholipid analogs useful as PAF synthesis inhibitors
CA1338627C (en) * 1985-12-04 1996-10-01 Hansjorg Eibl Pharmaceuticals based on phosphoric acid esters for use in tumor therapy, and process for their preparation
DE3829899C2 (en) * 1988-09-02 1994-12-15 Reutter Werner Glycerine glycophosphatides and pharmaceutical compositions containing them for combating skin diseases

Also Published As

Publication number Publication date
DD298052A5 (en) 1992-02-06
DE4029747C2 (en) 2003-10-02
FI904726A0 (en) 1990-09-26
IE903464A1 (en) 1991-04-10
DE4029747A1 (en) 1991-04-11
NO904184L (en) 1991-04-02
HU209589B (en) 1994-08-29
HUT55992A (en) 1991-07-29
EP0419998A2 (en) 1991-04-03
NO904184D0 (en) 1990-09-26
RU1837877C (en) 1993-08-30
CA2026278A1 (en) 1991-03-28
ZA907702B (en) 1991-07-31
LTIP1488A (en) 1995-06-26
LV10391A (en) 1995-02-20
EG19338A (en) 1994-12-30
EP0419998A3 (en) 1991-10-23
LV10391B (en) 1995-10-20
HU906233D0 (en) 1991-03-28
PT95422A (en) 1991-05-22
PT95422B (en) 1997-07-31
LT3804B (en) 1996-03-25
EP0916343A1 (en) 1999-05-19
UA19335A (en) 1997-12-25
CA2026278C (en) 1996-04-30
JP3176615B2 (en) 2001-06-18
JPH03130228A (en) 1991-06-04

Similar Documents

Publication Publication Date Title
MA21682A1 (en) PROCESS FOR THE PREPARATION OF THERAPEUTIC AGENTS DERIVED FROM QUAINCLIDINE.
NO851695L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 2- (N-SUBSTITUTED-GUANIDINO) -4-HETEROARYL-TIAZOL DERIVATIVES
FR2499414B1 (en) PRODUCTION OF HUMAN PROTEIN ANTIBODIES
MA21413A1 (en) NEW PROCESS FOR THE PREPARATION OF ALCOXY-GUANINE
FR2627493B1 (en) PROCESS FOR THE PREPARATION OF ISOQUINOLEIN DERIVATIVES
TR22747A (en) CONVENIENTIZERS FOR CONTROL OF WAGON SUERAT
MC2150A1 (en) USE OF ALKYLPHOPHORIC ACID DERIVATIVES FOR THE CONTROL OF PSORIASIS DISEASES
FR2630735B1 (en) PROCESS FOR THE PREPARATION OF HALOGENOPHENOLS
FR2565590B1 (en) PROCESS FOR THE PREPARATION OF AMINOHYDROXYCEPHAMCARBOXYLATES
FR2576902B1 (en) PROCESS FOR THE MANUFACTURE OF HYDROGENO-SILANES
FI93216C (en) Analogous process for the preparation of therapeutically useful 1,3-dioxanoic acid derivatives
CS22891A2 (en) Application of benzylphosphonic acid's derivatives for treatment of virusinduced diseases
IT1274494B (en) PHOTOCHEMICAL PROCEDURE FOR THE PREPARATION OF 13-CIS-RETINOIC ACID
FR2561645B1 (en) PROCESS FOR THE PREPARATION OF HYDROXYALKYLAMINOACETIC ACIDS
FR2628420B1 (en) PROCESS FOR THE PREPARATION OF METHOCARBAMOL
FR2630741B1 (en) PROCESS FOR THE PREPARATION OF ACRYLOYLOXYETHOXYMETHYL-MELAMINES
GR3000552T3 (en) Use of 7-chloroquinoline-8-carboxylic acids for influencing the development of crops
FR2610924B1 (en) PROCESS FOR THE PREPARATION OF HYDROXYBIPHENYLES
FR2560199B1 (en) PROCESS FOR THE PREPARATION OF I-BRASSICASTEROL
IT9021609A0 (en) PLANT FOR THE PRODUCTION OF FOOTWEAR AND PROCEDURE FOR THE USE OF SAID PLANT
NO852741L (en) PROCEDURE FOR THE PREPARATION OF THERAPEUTIC ACTIVE 5,6-DIHYDRO-4H-CYCLOPENTA (B) THIOFEN-6-CARBOXYLIC ACID DERIVATIVES
FR2564833B1 (en) PROCESS FOR THE PREPARATION OF IMIDAZOLIDINE DERIVATIVES
RO91889A2 (en) PROCESS FOR THE PREPARATION OF AZOBISISOBUTYRONITRYLE
FR2572072B1 (en) PROCESS FOR THE PREPARATION OF INDOLE DERIVATIVES
FR2565970B1 (en) PROCESS FOR THE PREPARATION OF AMINOBENZYLAMINES

Legal Events

Date Code Title Description
YP Annual fee paid